Medtronic launch new Insulin Pump in the US

Medtronic announces the US launch of the MiniMed 630G System with New User-Friendly Insulin Pump Design and SmartGuard Technology


Medtronic's MiniMed 630G System

Medtronic plc announced the US commercial launch of its MiniMed 630G system with SmartGuard technology FDA approved for the treatment of people with diabetes mellitus sixteen years of age and older.

The MiniMed 630G features a new insulin pump hardware platform and new user-friendly design that combines personalized diabetes management with industry-leading clinical performance. The MiniMed 630G system is the newest member of the MiniMed family-the most prescribed integrated insulin delivery system brand in the world.

Also read: Medtronic strengthens commitment to Asia Pacific

The MiniMed 630G system exclusively uses the CONTOURNEXT LINK 2.4 blood glucose meter from Ascensia Diabetes Care to provide blood glucose test results that have been shown to be highly accurate. The meter automatically transmits blood glucose results to calculate boluses using the Bolus Wizard calculator and to calibrate the CGM sensor, which helps prevent manual entry errors. It also allows patients to discreetly give themselves a bolus of insulin remotely from the meter, providing added convenience to help patients manage their diabetes effectively.

"This latest innovation demonstrates Medtronic's vision to transform diabetes care to enable greater freedom and better health through a commitment to continually improving both outcomes and user experience," said Alejandro Galindo, president of the Intensive Insulin Management business at Medtronic.


Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email